NAD+ is in every living cell you have, and there's less of it in you now than there was at thirty. That decline is one of the few things in longevity science that almost everyone agrees on, and it's the reason a molecule most people had never heard of a decade ago now has a wellness clinic on every corner charging four figures to drip it into your arm.
First, the part that confuses everyone
NAD+ shows up on the shelf in two completely different forms, sold through two completely different channels, and people mix them up constantly.
The oral versions are capsules and powders of NMN and NR, two precursors your body converts into NAD+. They're sold as ordinary dietary supplements, openly, on Amazon and at the vitamin store, no prescription and no gray area. The other version is NAD+ itself, given by IV or as an injection, which is what wellness clinics sell and what research suppliers list as a freeze-dried vial. That injectable and compounded form is the one the research-use framing applies to. When you see a "research use only" line attached to NAD+, it's about the vial, not about the capsule in the supplement aisle.
Worth knowing before you spend anything, because the price difference between those two routes is enormous and the evidence behind them isn't the same either.
What it actually is
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme, not a peptide. Think of it as the currency your cells use to run their energy machinery. It's also the required fuel for two families of enzymes that matter in aging research. Sirtuins help regulate which genes are switched on and how cells repair their DNA. PARPs handle DNA damage. Neither can work without NAD+ on hand, so when NAD+ falls, the repair crew slows down. Eric Verdin's 2015 review in Science laid that argument out in full, connecting age-related NAD+ decline to mitochondrial problems, oxidative stress, and weakened DNA repair. That paper is the foundation most of the current interest sits on.
Why women in midlife are paying attention
Most NAD+ content is written either for biohackers or for the clinic trying to sell you a drip package. Neither one is speaking to the thing that actually drives women here.
It's usually the tiredness. Not sleepy tired. The kind where you slept fine and still feel like you're running the day at eighty percent. It arrives somewhere around perimenopause alongside a body composition that shifts without any change in what you're doing, workouts that take longer to recover from, and a grip on the jar lid that's not what it was. You mention it and get told it's stress, or age, or that your labs are normal.
NAD+ speaks directly to that because the research on it's about cellular energy production and repair capacity, which is the mechanical version of exactly what you're describing. That's a real reason to look into it, and also a reason to read the evidence carefully rather than take the clinic's word for it.
What the research actually shows
The evidence base here is bigger and more human than for almost anything else on this site. It's also more modest in its conclusions than the marketing suggests.
Two things are well established. First, oral precursors work biochemically. In a 2018 randomized, double-blind crossover trial, Martens and colleagues found that NR supplementation was well tolerated and reliably raised whole-blood NAD+ in healthy middle-aged and older adults. Igarashi's 2022 trial found the same with 250 mg a day of NMN over twelve weeks. The molecule gets in and the levels go up. That's not in serious dispute.
Second, the functional results are smaller and shakier. The Igarashi trial reported nominally significant improvements in gait speed and grip strength, and the researchers themselves said those results need larger confirmatory studies. A 2023 trial by Katayoshi's group looked at arterial stiffness after twelve weeks of NMN and found a trend toward improvement that didn't reach statistical significance, even though blood NAD+ clearly rose. The brain and neurodegeneration work is still almost entirely animal studies.
Worth noting for this audience specifically, the Igarashi trial enrolled healthy older men. A lot of the functional data wasn't collected in women, which is a familiar problem and one nobody selling this to you is likely to mention.
The part the drip clinic won't tell you
Raising your NAD+ level is a measurable, repeatable thing. Whether raising it makes you healthier or live longer is still an open question. Nobody has shown that NAD+ repletion extends human lifespan or meaningfully slows aging in people. The longevity claims come from animal models and from the mechanism itself, and mechanism is a hypothesis, not a result.
The injectable form has the thinnest human evidence of the three, despite being the most expensive by a wide margin. It reaches the bloodstream faster than oral precursors, which is a real difference in how the body handles it, but faster isn't the same as better studied.
Buying it without paying for the room
An IV drip at a longevity clinic buys you the same molecule you can compare per milligram on this site, plus a recliner, a nurse, and a markup that has nothing to do with the compound. Medicalization is what multiplies a price, not manufacturing cost, and the GLP-1 drugs made that lesson impossible to miss.
Two habits separate a smart buy from a bad one, and neither requires anyone's permission. Compare the real per-milligram price rather than the sticker price, because vial sizes vary wildly and the cheap-looking listing often isn't. And only buy from vendors who publish third-party purity and identity testing. Our price comparison and vendor directory exist for exactly that.
One honest line, said once. The injectable and compounded forms of NAD+ are sold for research, and no large human trials establish a safe dose or a long-term profile for them in people. The oral precursors are further along but their real-world benefits are still modest and unsettled. You already know that. You're an adult making an informed call about your own body, and that call is yours.